Article references (41 references )

  1. Shah BA, Padbury JF. Neonatal sepsis: an old problem with new insights. Virulence. 2014; 5(1): 170-178. PubMed | Google Scholar

  2. Brown DR, Kutler D, Rai B, Chan T, Cohen M. Bacterial concentration and blood volume required for a positive blood culture. J Perinatol. 1995; 15(2): 157-159. PubMed | Google Scholar

  3. Worthman H, Tryc A, Dirks M, Schuppner R, Brand K, Klawonn F, Lichtinghagen R,Weissenborn K. Lipopolysaccharide binding protein, interleukin-10, interleukin 6 and C-reactive protein blood levels in acute ischemic stroke patients with post-stroke infection. J Neuroinflammation. 2015; 12: 13. PubMed | Google Scholar

  4. Cekic C, Arabul M, Alper E, Pakoz ZB, Saritas E, Yuksel, Unsal B. Evaluation of the relationship between serum ghrelin, C-reactive protein and interleukin-6 levels, and disease activity in inflammatory bowel diseases. Hepatogastroenterology. 2014; 61 (133): 1196-1200. PubMed | Google Scholar

  5. Chan DK, Ho LY. Usefulness of C-reactive protein in the diagnosis of neonatal sepsis. Singapore Med J. 1997; 38(6): 252-255. PubMed | Google Scholar

  6. Philip AG, Mills PC. Use of C-reactive protein in minimizing antibiotic exposure: experience with infants initially admitted to a well-baby nursery. Pediatrics. 2000; 106(1): E4. PubMed | Google Scholar

  7. Hofer N, Zacharias E, Muller W, Resch B. An update on the use of C-reactive protein in early-onset neonatal sepsis: current insights and new tasks. Neonatology. 2012; 102 (1): 25-36. PubMed | Google Scholar

  8. Mussap M. Laboratory medicine in neonatal sepsis and inflammation. J Matern Fetal Neonatal Med. 2012; 25(Suppl 4): 32-34. PubMed | Google Scholar

  9. Chiesa C, Signore F, Assumma M, Buffone E, Tramontozzi P, Osborn JF, Pacifico L. Serial measurements of C-reactive protein and interleukin-6 in the immediate postnatal period: reference intervals and analysis of maternal and perinatal confounders. Clin Chem. 2001; 47 (6): 1016-1122. PubMed | Google Scholar

  10. Dammann O, Phillips TM, Allred EN, O'Shea TM, Paneth N, Van Marter LJ, Bose C, Ehrenkranz RA, Bednarek FJ, Naples M, Leviton A. Elgan study investigators, Mediators of fetal inflammation in extremely low gestational age newborns. Cytokine. 2001; 13(4): 234-239. PubMed | Google Scholar

  11. Lai MY, Tsai MH, Lee CW, Chiang MC, Lien R, Fu RH, Huang HR, Chu SM, Hsu JF. Characteristics of neonates with culture-proven bloodstream infection who have low levels of C-reactive protein (≤10 mg/L). BMC Infect Dis. 2015; 15: 320. PubMed | Google Scholar

  12. Maruna P, Nedelnikova K, Gurlich R. Physiology and genetics of procalcitonin. Physiol Res. 2000; 49(Suppl1): S57-S61. PubMed | Google Scholar

  13. Gendrel D, Bohuon C. Procalcitonin as a marker of bacterial infection. Pediatr Infect Dis J. 2000; 19(8): 679-687. PubMed | Google Scholar

  14. Yu Z, Liu J, Sun Q, Qiu Y, Han S, Guo X. The accuracy of the procalcitonin test for the diagnosis of neonatal sepsis: a meta-analysis. Scand J Infect Dis. 2010; 42(10): 723-733. PubMed | Google Scholar

  15. Aikawa N, Fujishima S, Endo S, Sekine I, Kogawa K, Yamamoto Y, Kushimoto S, Yukioka H, Kato N, Totsuka K, Kikuchi K, Ikeda T, Ikeda K, Harada K, Satomura S. Multicenter prospective study of procalcitonin as an indicator of sepsis. J Infect Chemother. 2005; 11(3): 152-159. PubMed | Google Scholar

  16. Monneret G, Labaune JM, Isaac C, Bienvenu F, Putet G, Binevenu J. Procalcitonin and C-reactive protein levels in neonatal infections. Acta Paediatr. 1997; 86(2): 209-212. PubMed | Google Scholar

  17. Nahar BS, Mannan MA, Noor K, Shahiddullah M. Role of serum procalcitonin and C-reactive protein in the diagnosis of neonatal sepsis. Bang Med Res Counc Bull. 2011; 37(2): 40-46. PubMed | Google Scholar

  18. Janota J, Stranak Z, Belohlavkova S, Mudra K, Simak J. Postnatal increase of procalcitonin in premature newborns is enhanced by chorioamnionitis and neonatal sepsis. Eur J Clin Invest. 2001; 31(11): 978-983. PubMed | Google Scholar

  19. Turner D, Hammerman C, Rudensky B, Schlesinger Y, Goia C, Schimmel MS. Procalcitonin in preterm infants during the first few days of life: introducing an age related nomogram. Arch Dis Child Fetal Neonatal Ed. 2006; 91 (4): F283-286. PubMed | Google Scholar

  20. Lopez Sastre JB, Solís DP, Serradilla VR, Colomer BF, Cotallo GD. Grupo de Hospitales Castrillo, Evaluation of procalcitonin for diagnosis of neonatal sepsis of vertical transmission. BMC Pediatr. 2007; 7: 9. PubMed | Google Scholar

  21. Chiesa C, Natale F, Pascone R, Osborn JF, Pacifico L, Bonci E, De Curtis M. C reactive protein and procalcitonin: reference intervals for preterm and term newborns during the early neonatal period. Clin Chim Acta. 2011; 412 (11-12): 1053-1059. PubMed | Google Scholar

  22. Chiesa C, Panero A, Rossi N, Stegagno M, De Giusti M, Osborn JF, Pacifico L. Reliability of procalcitonin concentrations for the diagnosis of sepsis in critically ill neonates. Clin Infect Dis. 1998; 26 (3): 664-672. PubMed | Google Scholar

  23. Seale A, Mwaniki M, Newton CR, Berkley JA. Maternal and early onset neonatal bacterial sepsis: burden and strategies for prevention in sub-Saharan Africa. Lancet Infect Dis. 2009; 9(7): 428-438. PubMed | Google Scholar

  24. Opal SM, Cohen J. Clinical gram-positive sepsis: does it fundamentally differ from gram-negative bacterial sepsis. Crit Care Med. 1999; 27(8): 1608-1616. PubMed | Google Scholar

  25. Monneret G, Labaune JM, Isaac C, Bienvenu F, Putet G, Bienvenu J. Increased serum procalcitonin levels are not specific to sepsis in neonates. Clin Infect Dis. 1998; 27(6): 1559-1561. PubMed | Google Scholar

  26. Pourcyrous M, Bada HS, Korones SB, Baselski V, Wong SP. Significance of serial Creactive protein responses in neonatal infection and other disorders. Pediatrics. 1993; 92(3): 431-435. PubMed | Google Scholar

  27. Ainbender E, Cabatu EE, Guzman DM, Sweet AY. Serum C-reactive protein and problems of newborn infants. J Pediatr. 1982; 101(3): 438-440. PubMed | Google Scholar

  28. Amponsah SK, Adjei GO, Enweronu-Laryea C, Bugyei KA, Hadji-Popovski K, Kurtzhals JA, Kristensen K. Population pharmacokinetic characteristics of amikacin in suspected cases of neonatal sepsis in a low-resource African setting: a prospective non-randomized single-site study. Curr Ther Res. 2017. (Accessed 14/4/2017)
  29. Tollner U. Early diagnosis of septicemia in the newborn: clinical studies and sepsis score. Eur J Pediatr. 1982; 138(4): 331-337. PubMed | Google Scholar

  30. Vergnano S, Buttery J, Cailes B, Chandrasekaran R, Chiappini E, Clark E, et al,. Neonatal infections: Case definition and guidelines for data collection, analysis, and presentation of immunisation safety data. Vaccine. 2016 Dec 1; 34(49): 6038-6046. PubMed | Google Scholar

  31. De BK, Smith LG, Owen WE, and Roberts WL. Performance characteristics of an automated high-sensitivity C-reactive protein assay on the Dimension RxL analyzer. Clin Chim Acta. 2002; 323(1-2): 151-155. PubMed | Google Scholar

  32. Sano M, Tatsumi N. Electro chemiluminescence immunoassay. Rinsho Byori. 1996; 44(11): 1076-1079. PubMed | Google Scholar

  33. Ng PC. Diagnostic markers of infection in neonates. Arch Dis Child Fetal Neonatal Ed. 2004; 89(3): F229-235. PubMed | Google Scholar

  34. Meisner M. Pathobiochemistry and clinical use of procalcitonin. Clin Chim Acta. 2002; 323(1-20): 17-29. PubMed | Google Scholar

  35. Ali AM, Walid FE, Abdelaziz SS. Procalcitonin versus C-reactive protein in neonatal sepsis. J Immunol Infect Dis. 2014; 1(1): 103. PubMed | Google Scholar

  36. Lemons JA, Bauer CR, Oh W, Korones SB, Papile LA, Stoll BJ, Verter J, Temprosa M, Wright LL, Ehrenkranz RA, Fanaroff AA, Stark A, Carlo W, Tyson JE, Donovan EF, Shankaran S, Stevenson DK. Very low birth weight outcomes of the National Institute of Child health and human development neonatal research network, January 1995 through December 1996, NICHD Neonatal Research Network. Pediatrics. 2001; 107(1): E1. PubMed | Google Scholar

  37. Bonac B, Derganc M, Wraber B, Hojker S. Interleukin-8 and procalcitonin in early diagnosis of early severe bacterial infection in critically ill neonates. Pflügers Arch-Eur J Physiol. 2000; 440(5 Suppl): R72-4. PubMed | Google Scholar

  38. Koskal N, Harmanci R, Cetinkaya M, HAcimustafaoglu M. Role of procalcitonin and CRP in diagnosis and follow-up of neonatal sepsis. Turk J Pediatr. 2007; 49(1): 21-29. PubMed | Google Scholar

  39. Park IH, Lee SH, Yu ST, Oh YK. Serum procalcitonin as a diagnostic marker of neonatal sepsis. Korean J Pediatr. 2014; 57(10): 4451-456. PubMed | Google Scholar

  40. Altunhan H, Annagur A, Ors R, Mehmetoglu I. Procalcitonin measurement at 24 hours of age may be helpful in the prompt diagnosis of early-onset neonatal sepsis. Int J Infect Dis. 2011; 15(12): e854-e858. PubMed | Google Scholar

  41. Kim EK, Lee BS, Lee JA, Jo HS, Park JD, Kim BI et al. Clinical availability of serum procalcitonin level in the diagnosis of neonatal bacterial infection. J Korean Soc Neonatol. 2001; 8: 211-221. Google Scholar